Robust Prediction of Personalized Cell Recognition from a Cancer Population by a Dual Targeting Nanoparticle Library
Source abstract
Abstract
Nanomaterials are used increasingly in diagnostics and therapeutics, particularly for malignancies. Efficient targeting of nanoparticles to specific cells is an important requirement for the development of successful nanoparticle‐based theranostics and personalized medicines. Gold nanoparticles are surface modified using a library of small organic molecules, and optionally folate, to investigate their ability to target four cell lines from common cancers, three having high levels of folate receptors expression. Uptake of these nanoparticles varies widely with surface chemistriy and cell lines. Sparse machine learning methods are used to computationally model surface chemistry–uptake relationships, to make quantitative predictions of uptake for new nanoparticle surface chemistries, and to elucidate molecular aspects of the interactions. The combination of combinatorial surface chemistry modification and machine learning models will facilitate the rapid development of targeted theranostics.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Computational Drug Discovery Methods · Machine Learning in Materials Science · Advanced Biosensing Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
CSIRO Manufacturing Clayton 3169 Australia
School of Chemistry and Chemical Engineering Shandong University Jinan 250100 China
Monash Institute of Pharmaceutical Sciences Parkville 3052 Australia
Latrobe Institute for Molecular Science Bundoora 3083 Australia
School of Chemical and Physical Sciences Flinders University Bedford Park 5042 Australia
References (25)
Show source-provided references
1. 10.1002/jps.2045710.1002/jps.20457 ↗
2. 10.1126/science.115516410.1126/science.1155164 ↗
3. Ran S. · Cancer Res. · 2002 · 62 · 6132
4. 10.1039/c1cc13284a10.1039/c1cc13284a ↗
5. 10.1073/pnas.141449911110.1073/pnas.1414499111 ↗
6. 10.1002/cmdc.20140006810.1002/cmdc.201400068 ↗
7. 10.1021/nl303144k10.1021/nl303144k ↗
8. 10.1038/nbt115910.1038/nbt1159 ↗
9. 10.1080/1062936X.2013.87436710.1080/1062936X.2013.874367 ↗
10. 10.1021/nl073015510.1021/nl0730155 ↗
11. Oh N. · Int. J. Nanomed. · 2014 · 9 · 51
12. 10.1007/s12274-014-0618-510.1007/s12274-014-0618-5 ↗
13. 10.1021/ja108527y10.1021/ja108527y ↗
14. 10.1016/j.jmgm.2014.10.00610.1016/j.jmgm.2014.10.006 ↗
15. 10.1016/B978-044452701-1.00007-710.1016/B978-044452701-1.00007-7 ↗
16. 10.1021/ci950164c10.1021/ci950164c ↗
17. 10.1016/j.ab.2004.12.02610.1016/j.ab.2004.12.026 ↗
18. 10.1016/j.bios.2015.06.01210.1016/j.bios.2015.06.012 ↗
19. 10.1016/j.surg.2013.06.04510.1016/j.surg.2013.06.045 ↗
20. Mauri A. · MATCH Commun. Math. Comput. Chem. · 2006 · 56 · 237
21. 10.1002/qsar.20081017310.1002/qsar.200810173 ↗
22. 10.1021/jm049621j10.1021/jm049621j ↗
23. 10.1021/jm980697n10.1021/jm980697n ↗
24. 10.1080/0892702000802237410.1080/08927020008022374 ↗
25. 10.1021/acs.jcim.5b0020610.1021/acs.jcim.5b00206 ↗